Nosratola D. Vaziri

Nosratola D. Vaziri's AcademicInfluence.com Rankings

Nosratola D. Vaziri

Philosophy

#3245

World Rank

#5288

Historical Rank

Logic

#1034

World Rank

#1652

Historical Rank

philosophy Degrees

Nosratola D. Vaziri

Biology

#3995

World Rank

#6026

Historical Rank

Endocrinology

#20

World Rank

#24

Historical Rank

Biochemistry

#397

World Rank

#473

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Nosratola D. Vaziri's Degrees

PhD Biochemistry University of California, Berkeley
Doctorate Medicine Stanford University

Why Is Nosratola D. Vaziri Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nosratola D. Vaziri's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. (2013) (796)
Chronic kidney disease alters intestinal microbial flora. (2013) (785)
Targeting the Transcription Factor Nrf2 to Ameliorate Oxidative Stress and Inflammation in Chronic Kidney Disease (2012) (555)
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. (2006) (490)
New insights into TGF-β/Smad signaling in tissue fibrosis. (2018) (461)
Expansion of Urease- and Uricase-Containing, Indole- and p-Cresol-Forming and Contraction of Short-Chain Fatty Acid-Producing Intestinal Microbiota in ESRD (2014) (445)
Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. (2010) (402)
Mechanisms of Disease: oxidative stress and inflammation in the pathogenesis of hypertension (2006) (384)
Circulating Biomarkers of Inflammation, Antioxidant Activity, and Platelet Activation Are Associated with Primary Combustion Aerosols in Subjects with Coronary Artery Disease (2008) (336)
Oxidative stress in uremia: nature, mechanisms, and potential consequences. (2004) (334)
Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. (2003) (331)
Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. (2006) (324)
Effect of Diet and Exercise Intervention on Blood Pressure, Insulin, Oxidative Stress, and Nitric Oxide Availability (2002) (314)
Air Pollution Exposures and Circulating Biomarkers of Effect in a Susceptible Population: Clues to Potential Causal Component mixtures and mechanisms (2009) (298)
Effect of uremia on structure and function of immune system. (2012) (285)
Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. (2004) (283)
Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. (2016) (275)
Role of Urea in Intestinal Barrier Dysfunction and Disruption of Epithelial Tight Junction in Chronic Kidney Disease (2012) (273)
Mechanisms of lead-induced hypertension and cardiovascular disease. (2008) (272)
Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension (2004) (262)
Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. (2006) (251)
Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. (2012) (249)
High Amylose Resistant Starch Diet Ameliorates Oxidative Stress, Inflammation, and Progression of Chronic Kidney Disease (2014) (239)
Enhanced Nitric Oxide Inactivation and Protein Nitration by Reactive Oxygen Species in Renal Insufficiency (2002) (229)
Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment. (2018) (211)
The aging kidney. (2008) (209)
Effect of Antioxidant Therapy on Blood Pressure and NO Synthase Expression in Hypertensive Rats (2000) (208)
Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. (1997) (206)
Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. (1998) (203)
The Gut as a Source of Inflammation in Chronic Kidney Disease (2015) (202)
Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. (1997) (196)
CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity (2012) (196)
Antioxidant-Rich Diet Relieves Hypertension and Reduces Renal Immune Infiltration in Spontaneously Hypertensive Rats (2003) (190)
Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. (2000) (174)
Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. (2016) (172)
Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease. (2009) (171)
Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease (2019) (170)
Enhanced NO Inactivation and Hypertension Induced by a High-Fat, Refined-Carbohydrate Diet (2000) (167)
Dysregulation of Hepatic Superoxide Dismutase, Catalase and Glutathione Peroxidase in Diabetes: Response to Insulin and Antioxidant Therapies (2004) (164)
Intra-Renal Angiotensin II/AT1 Receptor, Oxidative Stress, Inflammation, and Progressive Injury in Renal Mass Reduction (2007) (161)
Naïve and central memory T-cell lymphopenia in end-stage renal disease. (2006) (159)
Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells. (2000) (158)
Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy (2015) (152)
Chronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight Junction (2013) (150)
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. (2016) (148)
Lipid Disorders and Their Relevance to Outcomes in Chronic Kidney Disease (2011) (146)
Early and Sustained Inhibition of Nuclear Factor-κB Prevents Hypertension in Spontaneously Hypertensive Rats (2005) (146)
Molecular mechanisms of lipid disorders in nephrotic syndrome. (2003) (146)
Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension. (2003) (145)
HDL metabolism and activity in chronic kidney disease (2010) (145)
A high-fat, refined-carbohydrate diet induces endothelial dysfunction and oxidant/antioxidant imbalance and depresses NOS protein expression. (2005) (144)
Association of Renal Injury with Increased Oxygen Free Radical Activity and Altered Nitric Oxide Metabolism in Chronic Experimental Hemosiderosis (2000) (141)
Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis (2015) (140)
Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. (2001) (140)
Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression (2009) (140)
Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis. (1994) (138)
Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression (2016) (138)
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan (2019) (138)
Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy. (2013) (137)
Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. (2003) (137)
Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl (2014) (137)
Causal link between oxidative stress, inflammation, and hypertension. (2008) (134)
Skeletal muscle dysfunction in chronic renal failure: effects of exercise. (2006) (133)
Hypertension as an autoimmune and inflammatory disease (2016) (132)
Novel inhibitors of the cellular renin‐angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β‐catenin pathway against renal fibrosis (2018) (130)
Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. (2009) (130)
Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. (2008) (128)
Mechanisms of dyslipidemia of chronic renal failure (2006) (127)
Air pollution and circulating biomarkers of oxidative stress (2011) (127)
An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure (2016) (127)
Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure. (2001) (125)
Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. (2014) (124)
Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease (2017) (123)
Uremic Plasma Impairs Barrier Function and Depletes the Tight Junction Protein Constituents of Intestinal Epithelium (2012) (123)
Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. (1996) (122)
Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. (2007) (120)
Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease. (2012) (120)
Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. (1998) (117)
Evolution of Renal Interstitial Inflammation and NF-κB Activation in Spontaneously Hypertensive Rats (2004) (117)
In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. (2009) (115)
Upregulation of Angiotensin II Type 1 Receptor, Inflammatory Mediators, and Enzymes of Arachidonate Metabolism in Obese Zucker Rat Kidney: Reversal by Angiotensin II Type 1 Receptor Blockade (2005) (114)
Erythropoietin depresses nitric oxide synthase expression by human endothelial cells. (1999) (113)
UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry. (2014) (113)
Effect of salt loading on nitric oxide synthase expression in normotensive rats. (2001) (112)
Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. (2009) (112)
Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. (2018) (111)
Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure. (2009) (110)
HDL abnormalities in nephrotic syndrome and chronic kidney disease (2016) (110)
Down-regulation of hepatic LDL receptor expression in experimental nephrosis. (1996) (110)
Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure. (1999) (110)
Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension. (2001) (109)
Microbiome–metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease (2019) (107)
Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension. (2007) (107)
Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. (2005) (105)
Effect of chronic renal failure on nitric oxide metabolism. (2001) (105)
Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence. (2007) (103)
Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. (2003) (102)
Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. (2008) (102)
Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells. (2007) (101)
Renal magnesium wasting associated with amphotericin B therapy. (1984) (99)
Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. (2009) (99)
Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. (1984) (99)
Novel RAS Inhibitors Poricoic Acid ZG and Poricoic Acid ZH Attenuate Renal Fibrosis via a Wnt/β-Catenin Pathway and Targeted Phosphorylation of smad3 Signaling. (2018) (98)
Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells. (2004) (98)
Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant-rich diet (2004) (97)
Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis. (2003) (97)
Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. (1998) (95)
Erythropoietin and transferrin metabolism in nephrotic syndrome. (2001) (95)
The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus (2018) (93)
Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease. (2010) (92)
Lead-induced hypertension: Role of oxidative stress (2004) (92)
Nifedipine and diltiazem but not verapamil up-regulate endothelial nitric-oxide synthase expression. (2000) (91)
Role of Intrarenal Angiotensin System Activation, Oxidative Stress, Inflammation, and Impaired Nuclear Factor-Erythroid-2-Related Factor 2 Activity in the Progression of Focal Glomerulosclerosis (2011) (91)
Upregulation of NOS by simulated microgravity, potential cause of orthostatic intolerance. (2000) (91)
Down-regulation of VLDL receptor expression in chronic experimental renal failure. (1997) (90)
Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine (1987) (89)
Effect of Lead on Nitric Oxide Synthase Expression in Coronary Endothelial Cells: Role of Superoxide (2001) (89)
Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. (1998) (88)
Bardoxolone methyl decreases megalin and activates nrf2 in the kidney. (2012) (88)
Oral Activated Charcoal Adsorbent (AST-120) Ameliorates Chronic Kidney Disease-Induced Intestinal Epithelial Barrier Disruption (2013) (87)
The link between phenotype and fatty acid metabolism in advanced chronic kidney disease (2017) (86)
Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients. (2014) (85)
Effects of Dietary Salt on Intrarenal Angiotensin System, NAD(P)H Oxidase, COX-2, MCP-1 and PAI-1 Expressions and NF-κB Activity in Salt-Sensitive and -Resistant Rat Kidneys (2007) (85)
Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: reversal by lifelong antioxidant supplementation. (2004) (84)
Intestinal excretion of oxalate in chronic renal failure. (1994) (84)
Urea, a true uremic toxin: the empire strikes back. (2016) (84)
Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism. (2017) (84)
Cardiovascular effects of erythropoietin and anemia correction (2001) (84)
Innovation in the Treatment of Uremia: Proceedings from the Cleveland Clinic Workshop: Causes of Dysregulation of Lipid Metabolism in Chronic Renal Failure (2009) (82)
NAD(P)H oxidase, superoxide dismutase, catalase, glutathione peroxidase and nitric oxide synthase expression in subacute spinal cord injury (2004) (80)
Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease (2014) (80)
Lipidomics: new insight into kidney disease. (2015) (80)
Leukocyte Toll-Like Receptor Expression in End-Stage Kidney Disease (2010) (79)
Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease. (2008) (79)
Small molecule inhibitors of epithelial‐mesenchymal transition for the treatment of cancer and fibrosis (2019) (79)
Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON) (2013) (79)
The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure. (2004) (78)
Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy. (2017) (78)
Nitric oxide synthase isotype expression in salt-sensitive and salt-resistant Dahl rats. (1999) (77)
Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis. (1995) (77)
Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension. (2003) (77)
Up-regulation of renal and vascular nitric oxide synthase in iron-deficiency anemia. (1997) (76)
Associations of oxidative stress and inflammatory biomarkers with chemically-characterized air pollutant exposures in an elderly cohort. (2016) (76)
Reversibility of Chronic Experimental Syndrome X by Diet Modification (2001) (75)
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease (2013) (75)
Wnt signaling pathway in aging-related tissue fibrosis and therapies (2020) (74)
Lipidomics Biomarkers of Diet-Induced Hyperlipidemia and Its Treatment with Poria cocos. (2016) (74)
Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome. (1999) (74)
Thyroid function studies in the nephrotic syndrome. (1979) (74)
Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy. (1994) (74)
Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome. (2001) (74)
Resveratrol restored Nrf2 function, reduced renal inflammation, and mitigated hypertension in spontaneously hypertensive rats. (2015) (74)
Down-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure. (2005) (73)
Pathogenesis of lead-induced hypertension: role of oxidative stress. (2002) (73)
Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis. (2013) (73)
Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia. (2015) (73)
Iron toxicity: relevance for dialysis patients. (2014) (72)
Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2 (2015) (72)
Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia. (2002) (71)
Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans. (2016) (71)
Lead-induced hypertension. III. Increased hydroxyl radical production. (2001) (70)
Soluble cytokine receptors and receptor antagonists are sequentially released after trauma. (1995) (69)
LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD. (2017) (69)
Expression of catalase and glutathione peroxidase in renal insufficiency. (2005) (68)
Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. (2010) (68)
Role of Nrf2 Dysfunction in Uremia-Associated Intestinal Inflammation and Epithelial Barrier Disruption (2015) (68)
Immunologic studies of anaphylaxis to iron dextran in patients on renal dialysis. (1994) (67)
LCZ696 (Sacubitril/Valsartan), an Angiotensin-Receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy, Fibrosis, and Vasculopathy in a Rat Model of Chronic Kidney Disease. (2018) (67)
Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis (2019) (67)
Enhanced Yields of Gamma Interferon in Prolactin Treated Human Peripheral Blood Mononuclear Cells (1994) (67)
Role of HDL dysfunction in end-stage renal disease: a double-edged sword. (2013) (66)
Enhanced enteric excretion of urate in rats with chronic renal failure. (1994) (66)
Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome. (2002) (65)
Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat. (2005) (64)
Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. (2002) (64)
Plasma PCSK9 in nephrotic syndrome and in peritoneal dialysis: a cross-sectional study. (2014) (64)
Down-regulation of hepatic lipase expression in experimental nephrotic syndrome. (1997) (64)
Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity. (2005) (64)
Vascular hyporesponsiveness in simulated microgravity: role of nitric oxide-dependent mechanisms. (2000) (64)
Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions. (2000) (63)
Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis. (2002) (63)
Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats. (2002) (62)
Nephrotoxicity of paraquat in man. (1979) (62)
Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation (2020) (60)
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression (2011) (60)
Acquired VLDL receptor deficiency in experimental nephrosis. (1997) (60)
Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis. (2019) (60)
Vitamin D, parathormone, and calcitonin profiles in persons with long-standing spinal cord injury. (1994) (60)
Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation (2018) (59)
Niacin improves renal lipid metabolism and slows progression in chronic kidney disease. (2010) (59)
Thiamin uptake by the human-derived renal epithelial (HEK-293) cells: cellular and molecular mechanisms. (2006) (59)
Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease (2018) (59)
African Americans, hypertension and the renin angiotensin system. (2014) (59)
Coagulation, fibrinolytic and inhibitory proteins in acute myocardial infarction and angina pectoris. (1992) (58)
A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice. (2011) (58)
Association of renal injury with nitric oxide deficiency in aged SHR: prevention by hypertension control with AT1 blockade. (2002) (57)
The Role of Oxidative Stress in Pancreatic β Cell Dysfunction in Diabetes (2021) (56)
Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure. (1997) (56)
Effect of high amylose resistant starch (HAM‐RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial (2018) (56)
Iron Sucrose Promotes Endothelial Injury and Dysfunction and Monocyte Adhesion/Infiltration (2011) (56)
Adverse Effects of Simulated Hyper- and Hypo-Phosphatemia on Endothelial Cell Function and Viability (2011) (56)
Serum uric acid, protein intake and mortality in hemodialysis patients (2017) (55)
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century (2016) (55)
Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain (2007) (55)
Amylose resistant starch (HAM‐RS2) supplementation increases the proportion of Faecalibacterium bacteria in end‐stage renal disease patients: Microbial analysis from a randomized placebo‐controlled trial (2019) (55)
Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure. (1998) (55)
Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome. (2014) (55)
Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease. (2009) (55)
Cardiovascular effects of lead exposure. (2008) (55)
Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. (1994) (54)
The Chronic Kidney Disease—Colonic Axis (2015) (54)
Effect of chronic kidney disease on the expression of thiamin and folic acid transporters. (2011) (53)
Chronic exposure to low doses of lead results in renal infiltration of immune cells, NF-kappaB activation, and overexpression of tubulointerstitial angiotensin II. (2005) (53)
The nature, consequences, and management of neurological disorders in chronic kidney disease (2018) (53)
Acquired renal cystic disease in renal transplant recipients. (1984) (53)
Gut hormones and gut microbiota: implications for kidney function and hypertension. (2016) (52)
Role of Oxidative Stress in the Pathogenesis of Pancreatitis: Effect of Antioxidant Therapy. (2013) (51)
Gene expression of lipoprotein lipase in experimental nephrosis. (1997) (51)
Changes of coagulation factors IX, VIII, VII, X, and V in nephrotic syndrome (1980) (51)
Effects of aortic coarctation on aortic antioxidant enzymes and NADPH oxidase protein expression. (2005) (51)
Pyridoxine uptake by colonocytes: a specific and regulated carrier-mediated process. (2008) (51)
Upregulation of monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) expression in end-stage renal disease. (2010) (51)
Nephrotic syndrome and coagulation and fibrinolytic abnormalities. (1983) (51)
The Effect of Nrf2 Pathway Activation on Human Pancreatic Islet Cells (2015) (50)
Renal transplantation in the elderly (2008) (50)
Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis. (2003) (50)
Salt-sensitive hypertension--update on novel findings. (2007) (50)
Pancreatic enzymes in patients with end-stage renal disease maintained on hemodialysis. (1988) (50)
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure. (2002) (50)
The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis. (2011) (50)
Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease (2019) (49)
Effect of recombinant human erythropoietin on platelet production in dialysis patients. (1993) (48)
Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCγ-1 and tyrosine kinase-Ras pathways. (1999) (48)
Congenital aneurysm of the membranous septum. (1965) (47)
Statins in the management of dyslipidemia associated with chronic kidney disease (2012) (47)
Exhaled breath and fecal volatile organic biomarkers of chronic kidney disease. (2013) (47)
Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy. (2019) (47)
Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate Restores Nrf2 Activity and Ameliorates Crescentic Glomerulonephritis (2015) (46)
Acyl-Coenzyme A:Cholesterol Acyltransferase Inhibition Ameliorates Proteinuria, Hyperlipidemia, Lecithin-Cholesterol Acyltransferase, SRB-1, and Low-Denisty Lipoprotein Receptor Deficiencies in Nephrotic Syndrome (2004) (46)
Chronic inflammatory disorders and accelerated atherosclerosis: chronic kidney disease. (2011) (46)
Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD (2012) (46)
HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X. (2004) (46)
Association of Serum Triglyceride to HDL Cholesterol Ratio with All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients. (2017) (45)
Effect of Synbiotic Therapy on Gut-Derived Uremic Toxins and the Intestinal Microbiome in Patients with CKD. (2016) (45)
ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure. (2004) (45)
Conductive pathways for chloride and oxalate in rabbit ileal brush-border membrane vesicles. (1998) (45)
Effect of Exercise on Cardiac Tissue Oxidative and Inflammatory Mediators in Chronic Kidney Disease (2008) (45)
The effect of pregnancy on renal clearance of boron in humans: a study based on normal dietary intake of boron. (2001) (45)
HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure. (2005) (45)
Effect of severe aortic banding above the renal arteries on nitric oxide synthase isotype expression. (2001) (44)
Reverse Cholesterol Transport Pathway in Experimental Chronic Renal Failure (2009) (44)
Biotin uptake by human proximal tubular epithelial cells: cellular and molecular aspects. (2005) (44)
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease☆ (2013) (43)
Effects of simulated microgravity on arterial nitric oxide synthase and nitrate and nitrite content. (2003) (42)
Mechanisms of oxalate absorption and secretion across the rabbit distal colon (2004) (42)
Coagulation cascade, fibrinolytic system, antithrombin III, protein C and protein S in patients maintained on continuous ambulatory peritoneal dialysis. (1989) (42)
Locus of control and adjustment to chronic hemodialysis. (1981) (42)
Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome. (2004) (41)
Plasma Norepinephrine, Epinephrine, and Dopamine Levels in End-Stage Renal Disease: Effect of Hemodialysis (1985) (41)
A high-fat, refined-carbohydrate diet affects renal NO synthase protein expression and salt sensitivity. (2003) (41)
Regulatory aspects of oxalate secretion in enteric oxalate elimination. (1999) (41)
Spectrum of renal abnormalities in acquired immune-deficiency syndrome. (1985) (40)
Hemodialysis of acute arsenic intoxication with transient renal failure. (1976) (40)
Silva's Diagnostic Renal Pathology (2010) (40)
Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD). (2009) (40)
Reversal of biochemical and behavioral parameters of brain aging by melatonin and acetyl l-carnitine (2002) (39)
Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease. (2015) (39)
Effect of hereditary obesity on renal expressions of NO synthase, caveolin-1, AKt, guanylate cyclase, and calmodulin. (2005) (39)
Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation. (2012) (39)
Identification of endogenous 1‐aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation (2020) (39)
The effect of pregnancy on renal clearance of boron in rats given boric acid orally. (2001) (38)
Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells. (1999) (38)
Chronic Kidney Disease Increases Cerebral Microbleeds in Mouse and Man (2019) (38)
The Leaky Gut and Altered Microbiome in Chronic Kidney Disease. (2017) (38)
Hypoxia-induced alterations of neutrophil membrane receptors. (1995) (37)
Gene expression of hepatic cholesterol 7 alpha-hydroxylase in the course of puromycin-induced nephrosis. (1996) (37)
Effects of aging and AT-1 receptor blockade on NO synthase expression and renal function in SHR. (2002) (36)
Effects of trauma on leukocyte intercellular adhesion molecule-1, CD11b, and CD18 expressions. (1995) (36)
Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. (2013) (36)
Activated NF-κB/Nrf2 and Wnt/β-catenin pathways are associated with lipid metabolism in CKD patients with microalbuminuria and macroalbuminuria. (2019) (36)
Coagulation and inhibitory and fibrinolytic proteins in essential hypertension. (1993) (35)
Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease? (2008) (35)
Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome. (1992) (35)
Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor (2019) (35)
Protective effects of estrogen on gender-specific development of diet-induced hypertension. (2001) (35)
Renal pathology in end-stage renal disease associated with paraplegia (1984) (35)
Tumor necrosis factor and monocytes are released during hemorrhagic shock. (1993) (35)
Voluntary exercise during chronic renal failure in rats. (2005) (34)
Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients. (2009) (34)
Iron Sucrose Impairs Phagocytic Function and Promotes Apoptosis in Polymorphonuclear Leukocytes (2012) (34)
Serum melatonin and 6-sulfatoxymelatonin in end-stage renal disease: effect of hemodialysis. (2008) (34)
Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma (2019) (34)
Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris. (1994) (33)
The Phosphate Binder Ferric Citrate Alters the Gut Microbiome in Rats with Chronic Kidney Disease (2018) (33)
Gene expression of LDL receptor, HMG-CoA reductase, and cholesterol-7 alpha-hydroxylase in chronic renal failure. (1997) (33)
Effect of Chronic Antioxidant Therapy with Superoxide Dismutase-Mimetic Drug, Tempol, on Progression of Renal Disease in Rats with Renal Mass Reduction (2009) (33)
Hemodialysis clearance of arsenic. (1980) (33)
Defective calcium signalling in uraemic platelets and its amelioration with long-term erythropoietin therapy. (2002) (33)
Characteristics of the transport of oxalate and other ions across rabbit proximal colon (1993) (33)
Boron and the kidney. (2005) (33)
Human uraemic plasma stimulates release of leptin and uptake of tumour necrosis factor-alpha in visceral adipocytes. (2009) (33)
Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes. (2005) (33)
Lead-induced hypertension is not associated with altered vascular reactivity in vitro. (1996) (32)
Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension. (1998) (32)
Effects of nerve graft on nitric oxide synthase, NAD(P)H oxidase, and antioxidant enzymes in chronic spinal cord injury. (2004) (32)
The effect of modified transurethral sphincterotomy on autonomic dysreflexia. (1986) (32)
Rhabdomyolysis and acute renal failure associated with phencyclidine intoxication. (1980) (32)
Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine. (1988) (32)
Effects of chronic renal failure on caveolin-1, guanylate cyclase and AKT protein expression. (2004) (32)
Nephrotic syndrome associated with adenocarcinoma of the breast. (1980) (32)
Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier. (2018) (32)
Expression of NOX-I, gp91phox, p47phox and P67phox in the aorta segments above and below coarctation. (2005) (32)
The Matrix Metalloproteinase-13 Inhibitor Poricoic Acid ZI Ameliorates Renal Fibrosis by Mitigating Epithelial-Mesenchymal Transition. (2019) (32)
Sustained systemic arterial hypertension induced by extended hypobaric hypoxia. (1996) (32)
Treatment with dimethyl fumarate ameliorates liver ischemia/reperfusion injury (2017) (32)
Lysophosphatidylcholine, Oxidized Low-Density Lipoprotein and Cardiovascular Disease in Korean Hemodialysis Patients: Analysis at 5 Years of Follow-up (2013) (32)
Toxicity with intravenous injection of crude marijuana extract. (1981) (31)
Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease. (2018) (31)
Iron and Oxidative Stress in Renal Insufficiency (2004) (31)
Femoral neuropathy: a complication of renal transplantation. (1981) (31)
Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport. (1996) (31)
Reasons for the Lack of Salutary Effects of Cholesterol-Lowering Interventions in End-Stage Renal Disease Populations (2013) (30)
Hypercholesterolemia in rats induces podocyte stress and decreases renal cortical nitric oxide synthesis via an angiotensin II type 1 receptor-sensitive mechanism. (2004) (30)
Hypertension induced by aortic coarctation above the renal arteries is associated with immune cell infiltration of the kidneys. (2005) (30)
Erythropoietin-induced hypertension in rat is not mediated by alterations of plasma endothelin, vasopressin, or atrial natriuretic peptide levels. (1997) (30)
Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites. (2017) (30)
Intestinal absorption of 5-methyltetrahydrofolate in experimental uremia. (1984) (30)
Dimethyl Fumarate Protects Pancreatic Islet Cells and Non-Endocrine Tissue in L-Arginine-Induced Chronic Pancreatitis (2014) (30)
Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum (2019) (30)
Redox signaling in aging kidney and opportunity for therapeutic intervention through natural products. (2019) (29)
Local upregulation of colonic angiotensin II receptors enhances potassium excretion in chronic renal failure. (1998) (29)
Urolithiasis in patients with spinal cord injury (1981) (29)
AT-1 receptor blockade prevents proteinuria, renal failure, hyperlipidemia, and glomerulosclerosis in the Imai rat. (2004) (29)
Effect of rapid weight loss with supplemented fasting on liver tests. (1987) (29)
Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease. (2011) (29)
Effects of chronic spinal cord injury and pressure ulcer on 25(OH)-vitamin D levels. (1993) (28)
Vitamin D Absorption, Plasma Concentration and Urinary Excretion of 25-Hydroxyvitamin D in Nephrotic Syndrome (1991) (28)
High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease (2010) (28)
Phencyclidine intoxication: clinical experience in 27 cases confirmed by urine assay. (1981) (28)
Gut microbial short-chain fatty acids and the risk of diabetes (2019) (28)
Impaired intestinal absorption of vitamin D3 in azotemic rats. (1983) (27)
Antioxidant therapy potentiates antihypertensive action of insulin in diabetic rats. (2001) (27)
Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCgamma-1 and tyrosine kinase-Ras pathways. (1999) (27)
HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia. (2003) (27)
Gut Microbial Translocation in the Pathogenesis of Systemic Inflammation in Patients with End-Stage Renal Disease (2014) (27)
Chronic hemodialysis in end-stage lupus nephritis: changes of clinical and serological activities. (1984) (27)
Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis. (2020) (26)
Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody-induced glomerulonephritis in mice. (2010) (26)
Sterol Regulatory Element-Binding Proteins, Liver X Receptor, ABCA1 Transporter, CD36, Scavenger Receptors A1 and B1 in Nephrotic Kidney (2009) (26)
Compression neuropathy subsequent to renal transplantation. (1976) (26)
Effect of hemodialysis on contact group of coagulation factors, platelets, and leukocytes. (1984) (26)
Iatrogenic iron overload and its potential consequences in patients on hemodialysis. (2017) (26)
Deficiency and urinary losses of factor XII in adult nephrotic syndrome. (1982) (26)
Nephrotic syndrome causes upregulation of HDL endocytic receptor and PDZK-1-dependent downregulation of HDL docking receptor. (2011) (26)
Effects of cyclosporine on magnesium metabolism in rats. (1989) (26)
Natural products against renin-angiotensin system for antifibrosis therapy. (2019) (26)
Effect of hemodialysis on leukocyte adhesion receptor expression. (1996) (26)
Implications of ethnicity for the treatment of hypertensive kidney disease, with an emphasis on African Americans (2008) (26)
Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure. (2004) (26)
Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE‐19) cells: mechanism and regulation (2007) (26)
Gases as uremic toxins: is there something in the air? (2014) (25)
Chronic Kidney Disease Results in Deficiency of ABCC6, the Novel Inhibitor of Vascular Calcification (2014) (25)
Cimetidine in the management of metabolic alkalosis induced by nasogastric drainage. (1979) (25)
Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy. (2005) (24)
Increased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury (2016) (24)
Endocrinological consequences of the nephrotic syndrome. (1993) (24)
Echocardiographic evaluation of the effect of hemodialysis on cardiac size and function in patients with end‐stage renal disease (1979) (24)
Chronic Sildenafil Treatment Corrects Endothelial Dysfunction and Improves Hypertension (2010) (24)
Central Retinal Vein Occlusion Associated with Hemodialysis (1979) (24)
Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial. (2013) (23)
Treatment With Dimethyl Fumarate Attenuates Calcineurin Inhibitor-induced Nephrotoxicity (2015) (23)
Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome. (2013) (23)
Pharmacological Activation of Nrf2 Pathway Improves Pancreatic Islet Isolation and Transplantation (2015) (23)
ApoA-1 Mimetic Peptide Reverses Uremia-Induced Upregulation of Pro-Atherogenic Pathways in the Aorta (2010) (23)
Impaired intestinal absorption of riboflavin in experimental uremia. (1985) (23)
Hemodialysis in treatment of acute chloral hydrate poisoning. (1977) (23)
Leukocyte CD11b and CD18 expression are increased in blood salvaged for autotransfusion. (1994) (22)
Effects of HMG-CoA Reductase Inhibition on Hepatic Expression of Key Cholesterol-Regulatory Enzymes and Receptors in Nephrotic Syndrome (2004) (22)
Participation of endoplasmic reticulum stress in the pathogenesis of spontaneous glomerulosclerosis--role of intra-renal angiotensin system. (2012) (22)
Dimethyl Fumarate Ameliorates Acute Pancreatitis in Rodent (2014) (22)
Salutary effect of pre-treatment with an Nrf2 inducer on ischemia reperfusion injury in the rat liver. (2014) (22)
Bacterial infections in patients with chronic renal failure: occurrence with spinal cord injury. (1982) (22)
Thrombocytosis in EPO-treated dialysis patients may be mediated by EPO rather than iron deficiency. (2009) (22)
Correction of long-term diet-induced hypertension and nitrotyrosine accumulation by diet modification. (2002) (22)
Blood pressure response to hypoxia: role of nitric oxide synthase. (2003) (22)
At pharmacologically relevant concentrations intravenous iron preparations cause pancreatic beta cell death. (2013) (22)
Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis. (1991) (22)
Intestinal absorption and biliary secretion of cholesterol in rats with nephrotic syndrome. (1998) (21)
Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations (2019) (21)
Downregulation of nitric oxide synthase in nephrotic syndrome: role of proteinuria. (2003) (21)
Lack of a fast-acting effect of erythropoietin on arterial blood pressure and endothelin level. (1995) (21)
Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome. (2007) (21)
Effects of a novel cystine-based glutathione precursor on oxidative stress in vascular smooth muscle cells. (2010) (20)
Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. (2010) (20)
Association of adiponectin and leptin with serum lipids and erythrocyte omega-3 and omega-6 fatty acids in dialysis patients. (2011) (20)
Effect of hemodialysis and diet on the exhaled breath methanol concentration in patients with ESRD. (2012) (20)
Inverse Association Between Serum Non–High‐Density Lipoprotein Cholesterol Levels and Mortality in Patients Undergoing Incident Hemodialysis (2018) (20)
Safety Issues in Iron Treatment in CKD. (2016) (20)
1‐Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway (2021) (20)
Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease (2019) (19)
Salt-sensitive hypertension in mitochondrial superoxide dismutase deficiency is associated with intra-renal oxidative stress and inflammation (2013) (19)
Event-related potential changes during hemodialysis. (1985) (19)
Regional Expression of NAD(P)H Oxidase and Superoxide Dismutase in the Brain of Rats with Neurogenic Hypertension (2008) (19)
Inactivators of fibroblast interferon found in human serum (1979) (19)
Increased levels of protein C activity, protein C concentration, total and free protein S in nephrotic syndrome. (1988) (19)
Effect of route of EPO administration on hemodialysis arteriovenous vascular access failure: a randomized controlled trial. (2009) (19)
Atherogenic lipoproteins and tyrosine kinase mitogenic signaling in mesangial cells. (1999) (19)
Dimethyl Fumarate Alleviates Dextran Sulfate Sodium-Induced Colitis, through the Activation of Nrf2-Mediated Antioxidant and Anti-inflammatory Pathways (2020) (19)
Preservation of urinary postprandial alkaline tide despite inhibition of gastric acid secretion. (1980) (19)
Acquired Renal Cystic Disease in Dialysis Patients (1982) (19)
Alisol B 23-acetate attenuates CKD progression by regulating the renin–angiotensin system and gut–kidney axis (2020) (19)
Effect of Chronic Renal Failure on Arginase and Argininosuccinate Synthetase Expression (2006) (19)
ESRD‐induced dyslipidemia—Should management of lipid disorders differ in dialysis patients? (2018) (18)
Hypertension: a complication of danazol therapy. (1980) (18)
Association of Serum Lipids with Outcomes in Hispanic Hemodialysis Patients of the West versus East Coasts of the United States (2015) (18)
Salutary effects of a novel oxidative stress modulator on adenine-induced chronic progressive tubulointerstitial nephropathy. (2012) (18)
Involvement of endothelium and endothelin-1 in lead-induced smooth muscle cell dysfunction in rats. (2006) (18)
Blood Coagulation, Fibrinolytic and Inhibitory Profiles in Renal Transplant Recipients: Comparison of Cyclosporine and Azathioprine (1992) (18)
Childbirth after renal transplantation. (1993) (18)
Increments in serum high-density lipoprotein cholesterol over time are not associated with improved outcomes in incident hemodialysis patients. (2018) (18)
Hemodialysis clearance of cimetidine. (1978) (17)
Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure. (1997) (17)
Integrin Expression and H2O2 Production in Circulating and Splenic Leukocytes of Obese Rats (2007) (17)
Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome (1993) (17)
Dialysis hypoxemia. Role of dialyzer membrane and dialysate delivery system. (1984) (17)
Peritoneal dialysis clearance of cimetidine. (1979) (16)
Effect of dimethylthiourea on paraquat toxicity in rats. (1984) (16)
Ineffectiveness of intravenous ascorbic acid as an acidifying agent in man. (1981) (16)
Role of gamma melanocyte-stimulating hormone-renal melanocortin 3 receptor system in blood pressure regulation in salt-resistant and salt-sensitive rats. (2009) (16)
Inhibition of apoptotic signalling in spermine‐treated vascular smooth muscle cells by a novel glutathione precursor (2010) (16)
Functional, biochemical, and histopathologic consequences of high-dose interleukin-2 administration in rats. (1991) (16)
Hemodialyzability of Acetazolamide (1980) (16)
Relationship between obesity and pulse pressure in children: results of the National Health and Nutrition Survey (NHANES) 1988-1994. (2012) (16)
Effects of conventional peritoneal dialysates on leukocyte adhesion and CD11b, CD18 and CD14 expression. (1996) (16)
Dietary tetrahydrocurcumin reduces renal fibrosis and cardiac hypertrophy in 5/6 nephrectomized rats (2018) (15)
Systemic and translesional activation of coagulation, fibrinolytic, and inhibitory systems in candidates for coronary angioplasty: basal state and effect of successful dilation. (1999) (15)
Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production. (2013) (15)
Respiratory physiology before and after hemodialysis in chronic renal failure patients (1979) (15)
Down-Regulation of Renal Endothelial Nitric Oxide Synthase Expression in Experimental Glomerular Thrombotic Microangiopathy (2000) (15)
The Effect of Somatostatin on the Production of Human Interferons by Mononuclear Cells (1990) (15)
Activation of intrinsic coagulation pathway in pre-eclampsia. (1986) (15)
Treatment of anemia of nephrotic syndrome with recombinant erythropoietin. (1996) (15)
Urinary excretion and deficiency of prothrombin in nephrotic syndrome. (1984) (14)
cAMP-dependent sulfate secretion by the rabbit distal colon: a comparison with electrogenic chloride secretion. (1997) (14)
Renal Tubular Dysfunction in Transplanted Kidneys (1979) (14)
Toxic effects of IV iron preparations in CKD patients. (2014) (14)
Phosphate Binder, Ferric Citrate, Attenuates Anemia, Renal Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in 5/6 Nephrectomized CKD Rats (2018) (14)
Thyroid function in chronic renal failure after successful renal transplantation. (1981) (14)
Dual role of circulating angiopoietin-like 4 (ANGPTL4) in promoting hypertriglyceridemia and lowering proteinuria in nephrotic syndrome. (2014) (14)
Childhood AIDS nephropathy: a 10-year experience. (1996) (14)
Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution (2017) (14)
Low albumin levels increase endothelial NO production and decrease vascular NO sensitivity. (2006) (14)
Effects of gender on hepatic HMG-CoA reductase, cholesterol 7alpha-hydroxylase, and LDL receptor in hereditary analbuminemia. (2005) (14)
New Options for Iron Supplementation in Maintenance Hemodialysis Patients. (2016) (14)
Effect of exercise training on aortic tone in chronic renal insufficiency. (2008) (14)
Radiodetoxified endotoxin-induced tolerance alters monocyte but not neutrophil CD11b and CD18 expression in response to lipopolysaccharide. (1994) (13)
Effect of acetyl salicylic acid on production and action of leukocyte-derived interferons (1987) (13)
Protective Effect of Nrf2 and Catalase in Maternal Diabetes-Induced Perinatal Hypertension and Kidney Disease (2012) (13)
The paradoxical effects of somatostatin on the bioactivity and production of cytotoxins derived from human peripheral blood mononuclear cells. (1991) (13)
Lipid fractions in primary hyperparathyroidism before and after surgical cure. (1983) (13)
ANTIOXIDANT THERAPY POTENTIATES ANTIHYPERTENSIVE ACTION OF INSULIN IN DIABETIC RATS (2002) (13)
Effect of hemodialysis on intraocular pressure. (1984) (13)
Pressure ulcer, fibronectin, and related proteins in spinal cord injured patients. (1992) (13)
Colorimetric rate method for the determination of creatinine as implemented by the Beckman Creatinine Analyzer 2. (1980) (13)
Lipid abnormalities in chronic renal failure associated with spinal cord injury (1982) (13)
Effect of heparin on mesangial cell growth and gene expression of matrix proteins. (1998) (13)
Massive mediastinal hematoma caused by a double-lumen subclavian catheter. (1984) (13)
Association of beta hydroxybutyric acidosis with isoniazid intoxication. (1984) (13)
Increased monocyte adhesion-promoting capacity of plasma in end-stage renal disease - response to antioxidant therapy. (2010) (13)
Decreased endothelial nitric oxide synthase in gastric mucosa of rats with chronic renal failure. (1998) (12)
Effect of erythropoietin administration on blood and plasma viscosity in hemodialysis patients. (1989) (12)
Augmentation of human natural killer cell activity by cyclophosphamide in vitro. (1984) (12)
Modulation of neutrophil complement receptor 3 expression by pneumococci. (2003) (12)
High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney. (2010) (12)
Induction, transcription, synthesis, and adsorption of interleukin-1 by dialyzer membranes. (1994) (12)
Erythropoietin Ameliorates Anemia of Cisplatin Induced Acute Renal Failure (1998) (12)
Erythropoietin profile in spinal cord injured patients. (1993) (12)
Effects of Experimental Hemosiderosis on Pancreatic Tissue Iron Content and Structure (1998) (11)
The consequences of altered microbiota in immune-related chronic kidney disease. (2020) (11)
Toxicity with intravenous injection of naphtha in man. (1980) (11)
Association of Serum Paraoxonase/Arylesterase Activity with All-Cause Mortality in Maintenance Hemodialysis Patients. (2019) (11)
Bradykinin Down-Regulates, Whereas Arginine Analogs Up-Regulates, Endothelial Nitric-Oxide Synthase Expression in Coronary Endothelial Cells (2005) (11)
Tubular mitochondrial AKT1 is activated during ischemia reperfusion injury and has a critical role in predisposition to chronic kidney disease. (2020) (11)
Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice (2022) (11)
Maintenance hemodialysis in myeloma kidney disease. (1977) (11)
Losartan antagonism of angiotensin-II-induced potassium secretion across rat colon (1998) (11)
Upregulation of cytochrome P450 1A2 in chronic renal failure: does oxidized tryptophan play a role? (2003) (10)
In-vivo and in-vitro hemodialysis studies of thiocyanate. (1982) (10)
Effect of chronic renal failure on intestinal transport of biotin in the rat. (1992) (10)
Severe hyperkalemia caused by indomethacin and potassium supplementation. (1985) (10)
Effect of resveratrol on progression of polycystic kidney disease: a case of cautious optimism. (2016) (10)
Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease (2019) (9)
Intestinal transport of pyridoxine in experimental renal failure. (1989) (9)
Effect of nephrotic syndrome on homocysteine metabolism. (2011) (9)
Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney. (2007) (9)
Synthetic Triterpenoid RTA dh404 (CDDO-dhTFEA) Ameliorates Acute Pancreatitis (2016) (9)
Focal renal cortical necrosis associated with zomepirac. (1984) (9)
Polyporus Umbellatus Protects Against Renal Fibrosis by Regulating Intrarenal Fatty Acyl Metabolites (2021) (9)
Cytokine levels during hemodialysis. (1991) (9)
Do thiazides reduce intestinal oxalate absorption?: a study in vitro using rabbit colon. (1994) (9)
The relationship of arterial compliance with endothelial-derived proteins of the hemostatic system. (1993) (9)
What should be the blood pressure target for patients with chronic kidney disease? (2013) (9)
Endocrine pathology in spinal cord injured patients on maintenance dialysis (1984) (9)
Special uses of cimetidine. (1978) (9)
Role of oxidative stress in the pathogenesis of erythropoietin-induced hypertension. (2010) (8)
Circulating Endocannabinoids and Mortality in Hemodialysis Patients (2020) (8)
Microarray Analysis of Altered Gene Expression in Kidneys of Adult Spontaneously Hypertensive Rats (2004) (8)
Title Role of RAS / Wnt / beta-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy (2017) (8)
The effect of beta-estradiol, progesterone and testosterone on the production of human leukocyte derived interferons. (1988) (8)
AT1 receptor up-regulation in intestine in chronic renal failure is segment specific (1999) (8)
Rapamycin treatment correlates changes in primary cilia expression with cell cycle regulation in epithelial cells. (2020) (8)
Simulated microgravity impairs vascular contractility: role of nitric oxide-dependent vasodilator mechanisms. (1999) (8)
Oral activated charcoal adsorbent (AST-120) ameliorates CKD-induced intestinal epithelial barrier disruption (2013) (8)
Intrinsic coagulation pathway in end-stage renal disease associated with spinal cord injury treated with hemodialysis. (1985) (8)
Immune Function in Chronic Kidney Disease (2020) (8)
Gastrointestinal pathology in patients with chronic renal failure associated with spinal cord injury. (1982) (8)
Lithium carbonate dose and serum level relationships in chronic hemodialysis patients. (1981) (8)
Inflammation, angiotensin II, and hypertension. (2008) (8)
Use of the gradient plate immunodiffusion technique. (1983) (8)
Effects of end‐stage renal disease and dialysis modalities on blood ammonia level (2017) (8)
Systemic upregulation of leukocyte integrins in response to lower body ischemia-reperfusion during abdominal aortic aneurysm repair. (2005) (7)
Protein C abnormalities in spinal cord injured patients with end-stage renal disease. (1987) (7)
Diabetes and the Gut Microbiome. (2021) (7)
Antithrombin III inhibits mesangial cell proliferation. (1996) (7)
Ferric Citrate Attenuates Cardiac Hypertrophy and Fibrosis in a Rat Model of Chronic Kidney Disease. (2019) (7)
Clinicopathological characteristics of dialysis patients with spinal cord injury. (1983) (7)
MicroarrayAnalysis of Altered Gene Expression in Kidneys of Adult Spontaneously Hypertensive Rats (2004) (7)
The Effect of Gonadotropins on the Production of Human Interferon-γ by Mononuclear Cells (1993) (7)
Risk factors: HDL-cholesterol levels and mortality in patients with ESRD (2014) (7)
Effect of Low Lead Exposure on Eicosanoid Excretion in Rats (1998) (7)
Clearance of Lidocaine by Hemodialysis (1979) (7)
Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate (2021) (6)
Comparison of hyperlipidemia in dialysis patients, renal transplant recipients, and steroid treated nonrenal patients. (1980) (6)
Potential Risks of Nitric Oxide Inhibition in Spinal Cord Injury (2007) (6)
Cytosolic ionized magnesium concentration in end-stage renal disease. Effect of hemodialysis. (1993) (6)
Effects of dietary fatty acid saturation on serum and tissue cholesterol concentrations and fecal sterol excretion: a chronic metabolic study in the rat. (1988) (6)
Prevention of metabolic alkalosis induced by gastric fluid loss using H2 receptor antagonist. (1985) (6)
Muscarinic down-regulation of cAMP-stimulated potassium ion secretion by rabbit distal colon (2000) (6)
Dihydroartemisinin suppresses renal fibrosis in mice by inhibiting DNA-methyltransferase 1 and increasing Klotho (2022) (6)
Cardiovascular pathology in renal transplant recipients. (1986) (6)
Renal changes with aging and end-stage renal disease (2014) (6)
Resveratrol restored Nrf 2 function , reduced renal inflammation , and mitigated hypertension in spontaneously hypertensive rats (2015) (6)
Adequate Dietary Calcium Mitigates Osteopenia Induced by Chronic Lead Exposure in Adult Rats (1999) (5)
The effect of gonadotropins on the production of human interferon-gamma by mononuclear cells. (1993) (5)
Comparison of four dialyzer-dialysate combinations: effects on blood gases, cell counts, complement contact factors and fibrinolytic system. (1984) (5)
Is contact activation of the coagulation system involved in the genesis of the first-use syndrome? (1987) (5)
Intestinal Absorption of l-Ascorbic Acid in Rats with Renal Failure (1989) (5)
Maintenance hemodialysis in end-stage renal disease associated with spinal cord injury. (1982) (5)
Adult nephrotic syndrome and acquired coagulopathies: Hageman factor deficiency. (1982) (5)
Extrinsic and common coagulation pathways in end-stage renal disease associated with spinal cord injury (1986) (5)
Adverse effects of (15S)-15-methyl-prostaglandin E1 in normal and paraquat-exposed rats. (1988) (5)
EFFECT OF DIET AND EXERCISE INTERVENTION ON INSULIN, HYPERTENSION AND NITRIC OXIDE AVAILABILITY (2002) (5)
Frequency and spectrum of pulmonary diseases in patients with chronic renal failure associated with spinal cord injury. (1983) (5)
Acute effects of dialysis on T lymphocytes in patients with end-stage renal disease. (1985) (5)
Calcium and the production of interferon by human peripheral blood mononuclear cells. (1988) (5)
Peritoneal dialysis clearance of endogenous lactate. (1979) (5)
The interrelationships of radioimmunoassayable urinary albumin, renal function and diabetes. (1986) (5)
Elevated Plasma Cyclophillin A in Hemodialysis and Peritoneal Dialysis Patients: a Novel Link to Systemic Inflammation. (2017) (5)
Microbiome–metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease (2019) (4)
T1881 Pyridoxine Uptake By Colonocytes: A Specific and Regulated Carrier-Mediated Process (2008) (4)
Hemodialysis studies of antidiuretic hormone. (1980) (4)
Cardiovascular pathology in dialysis patients with spinal cord injury. (1983) (4)
Renal complications of hepatitis C virus infection. (1996) (4)
The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper (2020) (4)
Statins in Chronic Kidney Disease: When and When Not to Use Them. (2016) (4)
Use of microanalytic laboratory methods to reduce blood loss in dialysis patients. (1979) (4)
Effect of rapid weight loss with supplemented fasting on serum electrolytes, lipids, and blood pressure. (1988) (4)
Pathophysiology of end-stage renal disease in spinal cord injury. (1993) (4)
Movement Disorders in Chronic Kidney Disease - A Descriptive Review. (2020) (4)
Intravenous digital subtraction angiography (DSA) of hemodialysis access fistulae. (1986) (4)
Activation of Nrf2 Restores Klotho Expression and Attenuates Oxidative Stress and Inflammation in CKD (2015) (4)
Lipid Disorders Associated with Chronic Kidney Disease and Nephrotic Syndrome (2019) (4)
The effect of vitamin D3 on the production of cytotoxic factors by human peripheral blood mononuclear cells. (1989) (4)
Intestinal morphometry and bile acid-induced mucosal injury in chronic experimental renal failure. (1990) (4)
Ticrynafen-induced acute renal failure. (1981) (4)
Effect of human insulin administration on urinary acidification in patients with insulin-dependent diabetes. (1987) (3)
Altered Lipid Metabolism and Serum Lipids in Kidney Disease and Kidney Failure (2013) (3)
Antithrombin deficiency in end-stage renal disease associated with paraplegia: effect of hemodialysis. (1985) (3)
Title Role of impaired Nrf 2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy Permalink (2013) (3)
Hypoalbuminemia after renal transplantation. (1980) (3)
UC Irvine UC Irvine Previously Published Works Title Plasma PCSK 9 in nephrotic syndrome and in peritoneal dialysis : A cross-sectional study (2013) (3)
Hyperoxaluria in chronic renal disease associated with spinal cord injury (1982) (3)
Hematologic features of chronic renal failure associated with spinal cord injury. (1982) (3)
SOLUBLE CYTOKINE RECEPTORS AND RECEPTOR ANTAGONISTS ARR SEQUENTIALLY RELEASED FOLLOWING TRAUMATIC INJURY (1994) (3)
Role of Nrf 2 Dysfunction in Uremia-Associated Intestinal Inflammation and Epithelial (2014) (3)
Urinary Excretion and Deficiency of Prothrombin in Nephrotic Syndrome (1985) (3)
Long-term haemodialysis in spinal cord injured patients (1984) (2)
Antidiuretic hormone in end-stage renal disease. (1980) (2)
Platelet-activating factor and the production of human interferon-gamma. (1997) (2)
Conductive pathways for chloride and oxalate in rabbit ileal brush-border membrane vesicles. (1998) (2)
Lactate dehydrogenase isoenzyme composition of human platelets. (1989) (2)
Ashokkumar B, Mohammed ZM, Vaziri ND, Said HM. Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells. Am J Clin Nutr 2007;86:159-66. (2010) (2)
Hemodialysis of Erythromycin (1980) (2)
Risk of Postoperative Venous Thromboembolism Among Pregnant Women. (2017) (2)
Peritoneal dialysis in renal failure associated with spinal cord injury. (1984) (2)
Cyclosporine nephrotoxicity. (1985) (2)
Evaluation of the in vitro production of interferon gamma and other lymphokines in uremic patients. (1987) (2)
factors activity in men with metabolic syndrome oxidative stress, inflammation, MMP-9, and monocyte Effect of a short-term diet and exercise intervention on (2006) (2)
Intestinal absorption of carnitine in experimental azotemia. (1990) (2)
Coagulation profile in persons with long-standing spinal cord injury. (1994) (2)
RNA Interference Targeting Liver Angiopoietin-Like Protein 3 Protects from Nephrotic Syndrome in a Rat Model Via Amelioration of Pathologic Hypertriglyceridemia (2020) (2)
Title The Effect of Nrf 2 Pathway Activation on Human Pancreatic Islet Cells Permalink (2015) (2)
Post-Transcriptional Nature of Uremia-induced Down-Regulation of hepatic Apolipoprotein A-I production - eScholarship (2012) (1)
Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients (2021) (1)
Subject Index, Vol. 32, 1982 (1982) (1)
Local upregulation of colonic angiotensin II receptors enhances potassium excretion in chronic renal failure. (1998) (1)
Effect of increased reactive oxygen species (ROS) on nitric oxide (NO) synthase (NOS) expression in cultured human endothelial cells. (1999) (1)
[Uremic toxins and gut micro biome]. (2017) (1)
Circulating Biomarkers of Inﬂammation, Antioxidant Activity, and Platelet Activation Are Associated with Primary Combustion Aerosols in Subjects with Coronary Artery Disease (2008) (1)
Lab methods / biomarkers (2013) (1)
Subject Index Vol. 24, 2004 (2004) (1)
Fibronectin and factor XIII in spinal cord injured patients with end-stage renal disease (1991) (1)
Focal Renal Cortical Necrosis Associated With Zomepirac (1985) (1)
Intestinal Absorption of Vitamin E in Experimental Renal Failure (1990) (1)
Pathology of digestive organs in renal transplant recipients. (1986) (1)
Dyslipidemia in Chronic Kidney Disease and Nephrotic Syndrome (2015) (1)
The effect of calcium-related factors on the predominance of IFN-gamma or interleukin-4 in cultured mononuclear cells. (1998) (1)
Reversal of the effects of cyclosporin A on the production of human interferon-gamma. (1987) (1)
Effects of glucose feeding on renal electrolyte and H+ transport. (1985) (1)
Effect of dimethylthiourea on plasma paraquat concentration. (1988) (1)
317 ANTIOXIDANT THERAPY DOES NOT AMELIORATE OXIDATIVE STRESS AND INFLAMMATION IN END-STAGE RENAL DISEASE PATIENTS. (2007) (1)
Route of intestinal absorption and tissue distribution of iron contained in the novel phosphate binder ferric citrate. (2020) (1)
Dyslipoproteinemia Associated with Chronic Renal Failure (2000) (1)
Effect of renal mass reduction on kidney tissue concentration of gentamycin following a single dose. (1988) (1)
Intestinal absorption of linoleic acid in experimental renal failure (1991) (1)
Intestinal absorption of vitamin A in experimental uremia. (1984) (1)
ROLE OF THE ENDOCANNABINOID SYSTEM IN ISCHEMIA-REPERFUSION RENAL INJURY (2013) (0)
Improved Islet Yield From UW Solution Preserved Pancreas With Dimethyl Fumarate Supplementation.: Abstract# C1720 (2014) (0)
of and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome. (2013) (0)
Title Treatment with dimethyl fumarate ameliorates liver ischemia / reperfusion injury (2017) (0)
Title Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease (2012) (0)
Mechanism, regulation and cell biology of vitamin B1 (thiamine) uptake by human retinal pigment epithelial ARPE‐19 cells. (2007) (0)
Lipid Disorders in CKD: nature and underlying molecular mechanisms 3.1. Dyslipidemia of CKD and ESRD 3.1.1. Alterations in triglyceride and triglyceride-rich lipoprotein metabolism 3.1.2. Alterations in cholesterol and low density lipoprotein metabolism (2017) (0)
4th Update on Fabry Nephropathy: Biomarkers, Progression and Treatment Opportunities. June 1-2, 2015, Manchester, UK: Abstracts (2015) (0)
Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review (2023) (0)
lipoprotein lipase expression in chronic renal failure Secondary hyperparathyroidism downregulates (2016) (0)
EFFECTOFRAPIDWEIGHTLOSS WITHSUPPLEMENTEDFASTINGON SERUMELECTROLYTES, LIPIDS, AND BLOODPRESSURE (1988) (0)
Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease (2019) (0)
Experimental pathology - 1 (2009) (0)
The effect of corticosteroids and other antineoplastic agents on the generation of leukocyte migration inhibition factor. (1987) (0)
Lithium carbonate dose and serum level relationship inchronic hemodialysis patients (1982) (0)
15th International Conference on Dialysis Advances in Chronic Kidney Disease 2013 (2013) (0)
Reassessment of fistula puncture site blood loss. (1979) (0)
Glomerulopressin in end-stage renal disease. Effect of hemodialysis. (1991) (0)
Corticosteroids and Granulopoiesis: Effects Upon In Vitro Colony Formation (1981) (0)
312 ROLE OF UP-REGULATION OF AT1 RECEPTOR IN OXIDATIVE STRESS, INFLAMMATION, AND PROGRESSIVE INJURY IN RENAL MASS REDUCTION. (2007) (0)
Treatment With the Nrf2 Activator, Dimethyl Fumarate, Ameliorates Calcineurin Inhibitor Nephrotoxicity in Rats.: Abstract# A55 (2014) (0)
Contents, Vol. 32, 1982 (1982) (0)
311 DIFFERENTIAL EFFECTS OF A HIGH-SALT DIET ON RENAL EXPRESSIONS OF AT1 RECEPTOR, NAD(P)H OXIDASE, COX-1, COX-2, SOD, GPX, MCP-1, AND PAI-1 IN SALT-SENSITIVE AND -RESISTANT RATS. (2007) (0)
MECHANISMS FOR BI·DIRECTIONAL OXALATE TRANSPORT ACROSS THE LARGE INTESTINE (1994) (0)
IS-1-6 Attenuation of experimental acute pancreatitis with Nrf2 activator therapy(IS-1 International Session (1) Pancreatic surgery) (2014) (0)
Serum concentrations of creatinine , urea , albumin , triglyceride , cholesterol and creatinine clearance , urine protein , systolic and diastolic blood pressure , weight gain , and kidney (2010) (0)
Title Increased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury (2016) (0)
Comparison of Serum Levels of Vitamins E and C and Dietary Antioxidants Intakes between Patients with Inflammatory Bowel Disease and Healthy Subjects (2009) (0)
Altered lipid metabolism and serum lipids in chronic kidney disease (2022) (0)
Title Endocannabinoid System and the Kidneys : From Renal Physiology to Injury and Disease (2019) (0)
Lipidomics Biomarkers of Diet-Induced Hyperlipidemia and Its Treatment with cocos. (2016) (0)
Title Risk factors : HDL-cholesterol levels and mortality in patients with ESRD Permalink (2014) (0)
Contents Vol. 37, 2013 (2013) (0)
EFFECTS OF HYPONIA ON INTERCELLULAR ADHESION MOLECULES ICAM-1 AND INTEGRINS CD118-CD18 EXPRESSION BY LEUKOCYTES (1994) (0)
Abstract TP256: Mouse Model of Uremic Cerebral Microbleeds (2016) (0)
acyltransferase in chronic renal failure Downregulation of hepatic acyl-CoA:diglycerol (2016) (0)
Fibrinolytic and protease inhibitory systems in spinal cord injured patients with end-stage renal disease. (1993) (0)
ROLE OF RENAL INSUFFICIENCY IN ALTERED ERYTHGROPOIETIN METABOLISM IN THE NEPHROTIC SYNDROME. AUTHOR REPLY (1992) (0)
Subject Index Vol. 29, 2009 (2009) (0)
Selected Abstracts from the 31th International Vicenza Course on Critical Care Nephrology. Vicenza, June 11-14, 2013 (2013) (0)
A pharmaco-metabolomic study of chronic aristolochic acid nephropathy (2014) (0)
Title ELEVATED PLASMA CYCLOPHILIN A IN HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS : A NOVEL LINK TO SYSTEMIC INFLAMMATION AND CARDIOVASCULAR DISEASE Permalink (2017) (0)
F021: Lead causes compensatory up-regulation of nitric oxide (NO) system in cultured endothelial cells—role of superoxide (2000) (0)
P-546: Upregulation of inflammatory mediators, cyclooxygenase-2, lipoxygenase and AT-1 receptor in the metabolic syndrome (2005) (0)
Effect of H2 histamine receptor blockade and stimulation on urinary acidification. (1985) (0)
Abstract 16746: Serum Paraoxonase Activity is a Better Predictor of Mortality than Serum HDL Cholesterol Level in Patients on Maintenance Hemodialysis (2017) (0)
Exploring the effect of Nrf2-keap1 pathway on acute pancreatitis (2013) (0)
Compensatory rise in vascular NO synthase (NOS) in young and severe NOS fall in old SHR: prevention with losartan therapy (1999) (0)
Inflammation Oxidative Stress Cardiovascular Impact Erythropoietic Impact NO , Endothelial Injury and Dysfunction + Oxidized Lipoproteins + Chemokines , Cytokines & Adhesion Molecules + Leukocyte Adhesion / Migration + Foam Cell Formation VSMC Migration / Transformation Atherosclerosis / Plaque Form (2009) (0)
Tetrahydrocurcumin Add‐On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury (2023) (0)
Title Participation of Endoplasmic Reticulum Stress in the Pathogenesis of Spontaneous Glomerulosclerosis-Role of Intra-Renal Angiotensin System Permalink (2012) (0)
Regional inactivation and sequestration of nitric oxide (NO) as nitrotyrosine in aortic coarctation-induced hypertension (HTN) (2000) (0)
Abstract 16243: Pre-ESRD Serum HDL Cholesterol Levels and One Year Post-ESRD Mortality in US Incident Hemodialysis Veterans: A Transition of Care in CKD Study (2017) (0)
Bacterial Infections-Reply (1983) (0)
Divergent effects of felodipine on nitric oxide synthase (NOS) expression in different forms of hypertension in rats. (1999) (0)
Title The link between phenotype and fatty acid metabolism in advanced chronic kidney disease Permalink (2017) (0)
Title Disorders of lipid metabolism in nephrotic syndrome : mechanisms and consequences (2016) (0)
Title Dimethyl Fumarate Ameliorates Acute Pancreatitis in Rodent Permalink (2014) (0)
Acute renal failure - basic research (2009) (0)
Abstract 15879: LCZ696, an Angiotensin-receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy and Fibrosis in a Rat Model of Chronic Kidney Disease (2016) (0)
Association of ureteropelvic pseudo-obstruction with cryptorchidism. (1985) (0)
Title Associations of oxidative stress and inflammatory biomarkers with chemically-characterized air pollutant exposures in an elderly cohort Permalink (2016) (0)
Lysophosphatidylcholine, Oxidized Low-Density Lipoprotein and Cardiovascular Disease in Korean Patients: Analysis at 5 Years of Follow-up (2013) (0)
Plasma and Urinary Catecholamines and Their Metabolites in Chromic Renal Failure (1984) (0)
Immunosuppressive and immunizing activities in human tumor cell-free extract. (1983) (0)
Endothelial Cells Calcium Channel Blockade Enhances Nitric Oxide Synthase Expression by Cultured (1998) (0)
protective effects of resveratrol against renal inflammation , oxidative stress , and development of hypertension in the SHR (2015) (0)
Contents Vol. 29, 2009 (2009) (0)
P-123: Evidence for the role of increased superoxide activity in the pathogenesis of lead-induced hypertension (HTN) (2001) (0)
Potential role of recombinant erythropoietin and intravenous iron preparations in target vessel re-stenosis following coronary stint insertions in hemodialysis patients. (2011) (0)
2 ) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients : a randomized clinical trial (2018) (0)
Mechanism and regulation of thiamin uptake in human‐derived renal epithelial cells (2006) (0)
ELEVATED PLASMA CYCLOPHILIN A IN HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS: A NOVEL LINK TO SYSTEMIC INFLAMMATION AND CARDIOVASCULAR DISEASE (2017) (0)
OR-70: Antioxidant supplementation beginning in the prenatal stage delays onset and attenuates severity of hypertension (HTN) in SHR (2003) (0)
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan (2019) (0)
Abstract 17172: Contrary to the General Population, Upward Increments in Serum High-density Lipoprotein Cholesterol Over Time Are Associated With Worse Survival in Incident Hemodialysis Patients (2016) (0)
Intestinal absorption of arachidonic acid in experimental azotemia. (1990) (0)
Prevalence of Aspergillus and Candida precipitins in renal dialysis and transplant patients. (1979) (0)
Inhibition of Hepatic Arginase activity in Chronic Renal Failure (CRF) (2006) (0)
Dialysis Staff Attitudes Toward Providing End-Stage Care (2008) (0)
Dimethyl Fumarate Prevents Acinar Damage From Rodent Chronic Pancreatitis Model With L-Arginine.: Abstract# C1706 (2014) (0)
Chronic Kidney Disease Increases Cerebral Microbleeds in Mouse and Man (2019) (0)
UC Irvine UC Irvine Previously Published Works Title Lipidomics : New Insight Into Kidney Disease (2015) (0)
Synthetic Triterpenoid RTA dh404 Ameliorates Acute Pancreatitis (2015) (0)
Contents Vol. 39, 2014 (2014) (0)
CHAPTER 60 – Hypertension and Epoetin Use in Dialysis Patients (2008) (0)
MP661ELEVATED PLASMA CYCLOPHILIN A IN HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS: A NOVEL LINK TO SYSTEMIC INFLAMMATION AND CARDIOVASCULAR DISEASE (2016) (0)
JPET #88062 Early and sustained inhibition of Nuclear Factor kappa B prevents hypertension in spontaneously hypertensive rats (2005) (0)
World Journal of Cardiology African Americans, hypertension and the renin angiotensin system (2014) (0)
Corrigendum to "A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice" (Exp. Mol. Pathol. Vol. 91 (2011) 419-429) (2012) (0)
Effect of Antioxidant Therapy on Nitric Oxide Synthase (NOS) Expression in Hypertensive Rats (2000) (0)
remnant kidney and dysregulation of lipid regulatory proteins in the Renal mass reduction results in accumulation of lipids (2016) (0)
UC Irvine UC Irvine Previously Published Works Title African Americans , hypertension and the renin angiotensin system (2014) (0)
Role of RAS/Wnt/ b -catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy Chemico-Biological Interactions (2017) (0)
Abstract 16728: LCZ696 Ameliorates Inflammation, Oxidative Stress and Prevents Disease Progression in a Rat Model of Chronic Kidney Disease (2016) (0)
Title Treatment with the Nrf 2 activator , Dimethyl Fumarate , ameliorates acute pancreatitis in a rodent model Permalink (2015) (0)
Oxidative stress and its implications in chronic kidney disease (2015) (0)
imbalance and depresses NOS protein expression endothelial dysfunction and oxidant/antioxidant A high-fat, refined-carbohydrate diet induces (2015) (0)
Role of Immunologic Mechanisms in Tubulointerstitial Nephropathies (1984) (0)
Contents Vol. 24, 2004 (2004) (0)
Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis (2019) (0)
Treatment With the Nrf2 Activator, Dimethyl Fumarate, Ameliorates Liver Ischemia/Reperfusion Injury in Rats.: Abstract# C1658 (2014) (0)
senescencehypertension and accelerated renal Association of mitochondrial SOD deficiency with (2015) (0)
HYPOXIA DECREASES NEUTROPHIL ATP LEVELS WHILE PROMOTING UPREGULATION OF ADHESION RECEPTORS. (1995) (0)
Hematopoietic system in paraplegic patients with end-stage renal disease. (1984) (0)
REVERSIBILITY OF CHRONIC INSULIN RESISTANCE AND OTHER FEATURES OF SYNDROME X BY DIET (2001) (0)
Effect of Experimental Azotemia on Intestinal Transport of Butyric Acid (1989) (0)
Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma (2019) (0)
Title Pharmacological activation of nrf 2 pathway improves pancreatic islet isolation and transplantation (2015) (0)
Exploring the Protective Effect of Nrf2 Activator On Ischemia Reperfusion Injury in Rat Liver.: Abstract# C2063 (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Nosratola D. Vaziri?

Nosratola D. Vaziri is affiliated with the following schools:

Nosratola D. Vaziri's Academic­Influence.com Rankings

Nosratola D. Vaziri's Degrees

Why Is Nosratola D. Vaziri Influential?

Nosratola D. Vaziri's Published Works

Published Works

What Schools Are Affiliated With Nosratola D. Vaziri?

Nosratola D. Vaziri's AcademicInfluence.com Rankings